Check-Cap Ltd. (CHEK) |
|
3.05 0.01 (0.33%)
|
01-27 16:00 |
|
Open: |
3.04 |
Pre. Close: |
3.04 |
|
High:
|
3.1316 |
Low:
|
3 |
|
Volume:
|
23,211 |
Market Cap:
|
18(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:43:20 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 4.3 One year: 5.03 |
| Support: |
Support1: 2.57 Support2: 1.87 |
| Resistance: |
Resistance1: 3.69 Resistance2: 4.3 |
| Pivot: |
2.95  |
| Moving Average: |
MA(5): 3.05 MA(20): 2.82
MA(100): 4.3  MA(250): 6.28 |
| MACD: |
MACD(12,26): 0 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 46.9 %D(3): 51.9 |
| RSI: |
RSI(14): 53.3 |
| 52-week: |
High: 14 Low: 0.31 |
| Average Vol(K): |
3-Month: 63 (K) 10-Days: 30 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CHEK ] has closed below upper band by 37.2%. Bollinger Bands are 52.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.13 - 3.15 |
3.15 - 3.16 |
|
Low:
|
2.96 - 2.98 |
2.98 - 3 |
|
Close:
|
3.02 - 3.05 |
3.05 - 3.07 |
|
Company Description |
|
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel. |
Headline News |
Sat, 28 Jan 2023
High-risk missing 16-year-old last seen on Jan. 24: Victoria Police - CHEK News
Sat, 28 Jan 2023
VicPD to review circumstances that led to family learning of son's death online - CHEK News
Sat, 28 Jan 2023
Arctic air to 'invade' Vancouver Island, parts of B.C.: Environment Canada - CHEK News
Fri, 27 Jan 2023
Developers excited about new opportunities following Missing Middle Housing vote - CHEK News
Fri, 27 Jan 2023
'Absolutely dumbfounded': Disability advocate demands apology over Oak Bay patio survey - CHEK News
Fri, 27 Jan 2023
Nanaimo RCMP say man at large after allegedly robbing store at knifepoint - CHEK News
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
6 (M) |
| Shares Float |
6 (M) |
|
% Held by Insiders
|
3.2 (%) |
|
% Held by Institutions
|
0.7 (%) |
|
Shares Short
|
37 (K) |
|
Shares Short P.Month
|
57 (K) |
Stock Financials |
|
EPS
|
-0.22 |
|
EPS Est Next Qtl
|
-0.15 |
|
EPS Est This Year
|
-0.63 |
|
EPS Est Next Year
|
-0.57 |
|
Book Value (p.s.)
|
7.71 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
-24.3 |
|
Return on Equity (ttm)
|
-41.4 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
-3.64 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-19 (M) |
|
Levered Free Cash Flow
|
-12 (M) |
Stock Valuations |
|
PE Ratio
|
-14.32 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.39 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-0.94 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2018-04-03 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
